Seronegative myasthenia gravis and human immunodeficiency virus infection: Response to intravenous gamma globulin and prednisone

Canadian Journal of Neurological Sciences

Volumn 25, Issue 3, 1998, Pages 254-256

  Strong, James ^a   Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN; LAMIVUDINE; PREDNISONE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0031818987     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100034119     Document Type: Article

References (19)

1. Bettaieb A, Oksenhendler E, Duedari N, Bierling P. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin Exp Immunol 1996; 103: 19-23.
2. Font J, Vidal J, Cervera R, et al. Lack of relationship between human immunodeficiency virus infection and systemic lupus erythematosus. Lupus 1995; 4: 47-49.
3. Gul A, Inanc M, Yilmaz G, et al. Antibodies reactive with HIV-1 antigens in systemic lupus erythematosus. Lupus 1996; 5: 120- 122.
4. Contreras G, Green DF, Pardo V, Schultz DR, Bourgoignie JJ. Systemic lupus erythematosus in two adults with human immunodeficiency virus infection. Am J Kidney Dis 1996; 28: 292-295.
5. Fraziano M, Montesano C, Lombardi VR, et al. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res Hum Retroviruses 1996; 12: 491-496.
6. Merrill JE, Graves MC, Mulder DG. Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update. West J Med 1992; 156: 639-646.
7. Authier FJ, De Grissac N, Degos JD, Gherardi RK. Transient myasthenia gravis during HIV infection. Muscle Nerve 1995; 18: 914-916.
8. Martini L, Vion P, Le Gangneux E, Grandpierre G, Becquet D. [AIDS and myasthenia: an uncommon association.] Rev Neurol (Paris) 1991; 147: 395-397.
9. Nath A, Kerman RH, Novak IS, Wolinsky JS. Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report. Neurology 1990; 40: 581-583.
10. Tiab M, Letortorec S, Michelet C, et al. [Occurrence of myasthenia in HIV infection.] Ann Med Interne (Paris) 1993; 144: 456-462.
11. Wessel HB, Zitelli BJ. Myasthenia gravis associated with human T- cell lymphotropic virus type III infection. Pediatr Neurol 1987; 3: 238-239.
12. Wullenweber M, Schneider U, Hagenah R. [Myasthenia gravis in AIDS and neurosyphilis.] Nervenarzt 1993; 64: 273-277.
13. Verma A, Berger J. Myasthenia gravis associated with dual infection of HIV and HTLV-I. Muscle Nerve 1995; 18: 1355-1356.
14. Vittecoq D, Morel C, Eymard B, Bach JF. Recovery from myasthenia gravis of a patient infected with human immunodeficiency virus. Clin Infect Dis 1992; 15: 379-380.
15. Birmanns B, Brenner T, Abramsky O, Steiner I. Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro. J Neurol Sci 1991; 102: 184-189.
16. Verma P, Oger J. Treatment of acquired autoimmune myasthenia gravis: a topic review. Can J Neurol Sci 1992; 19: 360-375.
17. Brunner NG, Berger CL, Namba T, Grob D. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Ann N Y Acad Sci 1976; 274: 577-595.
18. Gagnon S, Boota AM, Fischl MA, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med 1990; 323: 1444-1450.
19. Wilcox CM, Schwartz DA. A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection. Am J Med 1992; 93: 131- 134.